NVNO enVVeno Medical Corporation

$NVNO Ask yourself this , being at all time low and the second go around at the product. Why is there ZERO institutional interest, they have the resources to do DD well ahead of retail. They had the same issue the first time, only 2 or 3 institutional backers. There is a reason NO reputable institutional investor wants to touch Enveno. FDA approval doesnt mean increased value if no demand. #WTF FACT OR FICTION

$NVNO Burnt about 130-140 million to get to this point with nothing to show and a 5mil MC. Huge self-offering in the back and ATM waiting to be used on the smallest volume increase. Buy below 2 after the imminent dilution.

$NVNO 52 weeks low right now with 600K float. Could go parabolic once volume hits it, worth to add a lotto.

$NVNO Envveno medical's first-in-class envve system to be featured at the veins 2026 innovation summit as company advances toward u.s. pivotal trial